These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 14575803)

  • 1. Involvement of mast cell chymase in bleomycin-induced pulmonary fibrosis in mice.
    Tomimori Y; Muto T; Saito K; Tanaka T; Maruoka H; Sumida M; Fukami H; Fukuda Y
    Eur J Pharmacol; 2003 Oct; 478(2-3):179-85. PubMed ID: 14575803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The specific chymase inhibitor TY-51469 suppresses the accumulation of neutrophils in the lung and reduces silica-induced pulmonary fibrosis in mice.
    Takato H; Yasui M; Ichikawa Y; Waseda Y; Inuzuka K; Nishizawa Y; Tagami A; Fujimura M; Nakao S
    Exp Lung Res; 2011 Mar; 37(2):101-8. PubMed ID: 21128860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EM703 improves bleomycin-induced pulmonary fibrosis in mice by the inhibition of TGF-beta signaling in lung fibroblasts.
    Li YJ; Azuma A; Usuki J; Abe S; Matsuda K; Sunazuka T; Shimizu T; Hirata Y; Inagaki H; Kawada T; Takahashi S; Kudoh S; Omura S
    Respir Res; 2006 Jan; 7(1):16. PubMed ID: 16438734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of mast cell chymase inhibitor on the development of scleroderma in tight-skin mice.
    Shiota N; Kakizoe E; Shimoura K; Tanaka T; Okunishi H
    Br J Pharmacol; 2005 Jun; 145(4):424-31. PubMed ID: 15806109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chymase: a multifunctional player in pulmonary hypertension associated with lung fibrosis.
    Kosanovic D; Luitel H; Dahal BK; Cornitescu T; Janssen W; Danser AH; Garrelds IM; De Mey JG; Fazzi G; Schiffers P; Iglarz M; Fischli W; Ghofrani HA; Weissmann N; Grimminger F; Seeger W; Reiss I; Schermuly RT
    Eur Respir J; 2015 Oct; 46(4):1084-94. PubMed ID: 26113671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mast cell chymase inhibits smooth muscle cell growth and collagen expression in vitro: transforming growth factor-beta1-dependent and -independent effects.
    Wang Y; Shiota N; Leskinen MJ; Lindstedt KA; Kovanen PT
    Arterioscler Thromb Vasc Biol; 2001 Dec; 21(12):1928-33. PubMed ID: 11742866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mast cells contribute to bleomycin-induced lung inflammation and injury in mice through a chymase/mast cell protease 4-dependent mechanism.
    Reber LL; Daubeuf F; Pejler G; Abrink M; Frossard N
    J Immunol; 2014 Feb; 192(4):1847-54. PubMed ID: 24453258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mast cell chymase and tryptase during tissue turnover: analysis on in vitro mitogenesis of fibroblasts and keratinocytes and alterations in cutaneous scars.
    Algermissen B; Hermes B; Feldmann-Boeddeker I; Bauer F; Henz BM
    Exp Dermatol; 1999 Jun; 8(3):193-8. PubMed ID: 10389636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interferon-{beta} inhibits bleomycin-induced lung fibrosis by decreasing transforming growth factor-{beta} and thrombospondin.
    Azuma A; Li YJ; Abe S; Usuki J; Matsuda K; Henmi S; Miyauchi Y; Ueda K; Izawa A; Sone S; Hashimoto S; Kudoh S
    Am J Respir Cell Mol Biol; 2005 Feb; 32(2):93-8. PubMed ID: 15557019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Grape seed extract ameliorates bleomycin-induced mouse pulmonary fibrosis.
    Liu Q; Jiang JX; Liu YN; Ge LT; Guan Y; Zhao W; Jia YL; Dong XW; Sun Y; Xie QM
    Toxicol Lett; 2017 May; 273():1-9. PubMed ID: 28300665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucagon like peptide-1 attenuates bleomycin-induced pulmonary fibrosis, involving the inactivation of NF-κB in mice.
    Gou S; Zhu T; Wang W; Xiao M; Wang XC; Chen ZH
    Int Immunopharmacol; 2014 Oct; 22(2):498-504. PubMed ID: 25111852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural killer T (NKT) cells attenuate bleomycin-induced pulmonary fibrosis by producing interferon-gamma.
    Kim JH; Kim HY; Kim S; Chung JH; Park WS; Chung DH
    Am J Pathol; 2005 Nov; 167(5):1231-41. PubMed ID: 16251408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of paracrine TGF-beta1 signaling upon stimulation and degranulation of rat serosal mast cells: a novel function for chymase.
    Lindstedt KA; Wang Y; Shiota N; Saarinen J; Hyytiäinen M; Kokkonen JO; Keski-Oja J; Kovanen PT
    FASEB J; 2001 Jun; 15(8):1377-88. PubMed ID: 11387235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble epoxide hydrolase inhibitor AUDA decreases bleomycin-induced pulmonary toxicity in mice by inhibiting the p38/Smad3 pathways.
    Dong XW; Jia YL; Ge LT; Jiang B; Jiang JX; Shen J; Jin YC; Guan Y; Sun Y; Xie QM
    Toxicology; 2017 Aug; 389():31-41. PubMed ID: 28694203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic administration of inhaled INS1009, a treprostinil prodrug formulation, inhibits bleomycin-induced pulmonary fibrosis in rats.
    Corboz MR; Zhang J; LaSala D; DiPetrillo K; Li Z; Malinin V; Brower J; Kuehl PJ; Barrett TE; Perkins WR; Chapman RW
    Pulm Pharmacol Ther; 2018 Apr; 49():95-103. PubMed ID: 29408757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. VEGFR-2 antagonist SU5416 attenuates bleomycin-induced pulmonary fibrosis in mice.
    Ou XM; Li WC; Liu DS; Li YP; Wen FQ; Feng YL; Zhang SF; Huang XY; Wang T; Wang K; Wang X; Chen L
    Int Immunopharmacol; 2009 Jan; 9(1):70-9. PubMed ID: 18976720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mast cell chymase is a possible mediator of neurogenic bladder fibrosis.
    Howard PS; Renfrow D; Schechter NM; Kucich U
    Neurourol Urodyn; 2004; 23(4):374-82. PubMed ID: 15227657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of cordyceps sinensi on bleomycin-induced pulmonary fibrosis in mice].
    Wang SJ; Bai W; Wang CL; Dai Z
    Zhongguo Zhong Yao Za Zhi; 2007 Dec; 32(24):2623-7. PubMed ID: 18338602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paeoniflorin suppresses TGF-β mediated epithelial-mesenchymal transition in pulmonary fibrosis through a Smad-dependent pathway.
    Ji Y; Dou YN; Zhao QW; Zhang JZ; Yang Y; Wang T; Xia YF; Dai Y; Wei ZF
    Acta Pharmacol Sin; 2016 Jun; 37(6):794-804. PubMed ID: 27133302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Feitai, a Chinese herbal medicine, reduces transforming growth factor-beta1 and monocyte chemoattractant protein-1 expression in bleomycin-induced lung fibrosis in mice.
    Shen Y; Zhao HL; Du J; Li YT; Tan F; Huang CG; Pei G
    Clin Exp Pharmacol Physiol; 2005 Dec; 32(12):1071-7. PubMed ID: 16445573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.